| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58468-0132-2 | 58468-0132 | HUMAN PRESCRIPTION DRUG | Renvela | SEVELAMER CARBONATE | POWDER, FOR SUSPENSION | ORAL | 20090812 | N/A | NDA | NDA022318 | Genzyme Corporation | SEVELAMER CARBONATE | 800 mg/1 | 90 PACKET in 1 CARTON (58468-0132-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0132-1) |
| 58468-0131-2 | 58468-0131 | HUMAN PRESCRIPTION DRUG | Renvela | SEVELAMER CARBONATE | POWDER, FOR SUSPENSION | ORAL | 20090812 | N/A | NDA | NDA022318 | Genzyme Corporation | SEVELAMER CARBONATE | 2400 mg/1 | 90 PACKET in 1 CARTON (58468-0131-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0131-1) |
| 0955-1054-90 | 0955-1054 | HUMAN PRESCRIPTION DRUG | Sevelamer Carbonate | Sevelamer Carbonate | POWDER, FOR SUSPENSION | ORAL | 20180101 | N/A | NDA AUTHORIZED GENERIC | NDA022318 | Sanofi-Aventis U.S. LLC | SEVELAMER CARBONATE | 2.4 g/1 | 90 PACKET in 1 BOX (0955-1054-90) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0955-1054-01) |
| 0955-1052-90 | 0955-1052 | HUMAN PRESCRIPTION DRUG | Sevelamer Carbonate | Sevelamer Carbonate | POWDER, FOR SUSPENSION | ORAL | 20180101 | N/A | NDA AUTHORIZED GENERIC | NDA022318 | Sanofi-Aventis U.S. LLC | SEVELAMER CARBONATE | .8 g/1 | 90 PACKET in 1 BOX (0955-1052-90) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0955-1052-01) |